Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Drugs & Aging|July 26, 2013
Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderlyVirginie Siguret, Isabelle Gouin-Thibault, Pascale Gaussem, et al.
Thrombosis Research|April 12, 2011
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS)Alain Leizorovicz, Virginie Siguret, Dominique Mottier, et al.
European Heart Journal. Case Reports|June 9, 2021
Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case reportMaxime Coutrot, Maxime Delrue, Bérangère S Joly, et al.
Drug Safety|August 9, 2002
Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patientsEric Pautas, Isabelle Gouin, Oliver Bellot, et al.
Drugs & Aging|February 24, 2006
Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and managementEric Pautas, Isabelle Gouin-Thibault, Matthieu Debray, et al.
Soins. Gerontologie|June 25, 2011
[Management of complications with antivitamin K in elderly people]Eric Pautas, Nathalie Mitha, Adeline Gouronnec, et al.
JMIR Medical Education|April 10, 2025
Evaluation of the Inverted Classroom Approach in a Case-Study Course on Antithrombotic Drug Use in a PharmD Curriculum: French Monocentric Randomized StudyGeorges Jourdi, Mayssa Selmi, Pascale Gaussem, et al.
Thrombosis and Haemostasis|August 3, 2018
FXa-α2-Macroglobulin Complex Neutralizes Direct Oral Anticoagulants Targeting FXa In Vitro and In VivoGeorges Jourdi, Isabelle Gouin-Thibault, Virginie Siguret, et al.
La Revue Du Praticien|March 15, 2019
[Von Willebrand disease in the elderly]Nathalie Itzhar-Baïkian, Agnès Veyradier, Jean-Guillaume Dillinger, et al.
Journal of Stroke|January 2, 2023
Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke PatientsCharlyne Brakta, Alain Stépanian, Peggy Reiner, et al.
Pageof 9